Kiniksa Pharmaceuticals, Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 4.00 M | $155.32 M | 2.31% | 5.45% |
| VANGUARD GROUP INC | 11/07/2025 | 3.06 M | $118.94 M | -2.19% | 4.17% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 2.82 M | $109.68 M | 0.00% | 3.85% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.33 M | $90.42 M | 0.00% | 3.17% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 1.77 M | $68.84 M | 0.00% | 2.41% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 1.62 M | $62.82 M | 27.64% | 2.20% |
| MORGAN STANLEY | 11/14/2025 | 1.36 M | $52.92 M | 27.82% | 1.86% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 1.13 M | $44.04 M | 43.33% | 1.54% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 1.07 M | $41.48 M | 45.26% | 1.45% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.01 M | $39.38 M | -0.57% | 1.38% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 932.10 K | $36.19 M | -5.33% | 1.27% |
| FMR LLC | 11/13/2025 | 799.76 K | $31.05 M | -0.89% | 1.09% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 725.36 K | $28.17 M | 16.30% | 0.99% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 689.89 K | $26.79 M | -22.34% | 0.94% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 671.59 K | $26.08 M | 37.40% | 0.91% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 654.59 K | $25.42 M | 1.02% | 0.89% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 653.41 K | $25.37 M | 53.40% | 0.89% |
| BRAIDWELL LP | 11/14/2025 | 643.18 K | $24.97 M | -41.67% | 0.88% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 632.12 K | $24.55 M | -2.50% | 0.86% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 577.82 K | $22.44 M | -9.47% | 0.79% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 566.93 K | $22.01 M | -33.19% | 0.77% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 546.51 K | $21.22 M | 42.44% | 0.74% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 533.38 K | $20.71 M | 44.35% | 0.73% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 502.60 K | $19.52 M | 118.52% | 0.68% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 495.48 K | $19.24 M | 81.74% | 0.67% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 461.77 K | $17.93 M | 182.01% | 0.63% |
| JANE STREET GROUP, LLC | 11/14/2025 | 461.39 K | $17.92 M | -17.37% | 0.63% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10/29/2025 | 458.30 K | $17.80 M | 613.51% | 0.62% |
| BLACKROCK, INC. | 11/12/2025 | 457.65 K | $17.77 M | -34.89% | 0.62% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 413.09 K | $16.04 M | 244.57% | 0.56% |
| NOMURA HOLDINGS INC | 11/14/2025 | 397.14 K | $15.42 M | 100.00% | 0.54% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 381.32 K | $14.81 M | -42.00% | 0.52% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 359.84 K | $13.97 M | -21.26% | 0.49% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 340.63 K | $13.23 M | -26.89% | 0.46% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 332.42 K | $12.91 M | -16.53% | 0.45% |
| CITADEL ADVISORS LLC | 11/14/2025 | 314.56 K | $12.21 M | 17.64% | 0.43% |
| OBERWEIS ASSET MANAGEMENT INC/ | 11/17/2025 | 305.20 K | $11.85 M | 0.00% | 0.42% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 298.35 K | $11.58 M | -10.65% | 0.41% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 283.57 K | $11.01 M | -8.82% | 0.39% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2025 | 282.29 K | $10.96 M | 176.05% | 0.38% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 11/06/2025 | 247.30 K | $9.60 M | 44.25% | 0.34% |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 11/10/2025 | 225.37 K | $8.75 M | 12.36% | 0.31% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 10/23/2025 | 214.36 K | $8.32 M | -25.73% | 0.29% |
| JPMORGAN CHASE & CO | 11/26/2025 | 192.46 K | $7.47 M | 42.26% | 0.26% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 177.10 K | $6.88 M | 107.38% | 0.24% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 173.44 K | $6.73 M | 100.00% | 0.24% |
| SEI INVESTMENTS CO | 11/13/2025 | 171.17 K | $6.65 M | 68.65% | 0.23% |
| ABRDN PLC | 11/07/2025 | 158.72 K | $6.16 M | 100.00% | 0.22% |
| CASTLEARK MANAGEMENT LLC | 11/17/2025 | 158.63 K | $6.16 M | 100.00% | 0.22% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 150.00 K | $5.82 M | -41.10% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kiniksa Pharmaceuticals, Ltd. institutional Ownership - FAQ's
During the previous two years, 256 institutional investors and hedge funds held shares of Kiniksa Pharmaceuticals, Ltd.. The most heavily invested institutionals were:
Rubric Capital Management LP: 4 M
VANGUARD GROUP INC: 3.06 M
BAKER BROS. ADVISORS LP: 2.82 M
TANG CAPITAL MANAGEMENT LLC: 2.33 M
Fairmount Funds Management LLC: 1.77 M
ACADIAN ASSET MANAGEMENT LLC: 1.62 M
55.57% of Kiniksa Pharmaceuticals, Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 52.16 M shares in the last 24 months. This purchase volume represents approximately $2.01 B in transactions.